Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; sodium stearylfumarate; mannitol; crospovidone; silicified microcrystalline cellulose; magnesium stearate; stearic acid; hypromellose; macrogol 6000; titanium dioxide; purified talc; iron oxide yellow - treatment of major depression in adults including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty 25 mg) - tablet, film coated - excipient ingredients: mannitol; silicified microcrystalline cellulose; sodium stearylfumarate; colloidal anhydrous silica; povidone; crospovidone; magnesium stearate; stearic acid; hypromellose; macrogol 6000; titanium dioxide; purified talc; iron oxide yellow - treatment of major depression in adults including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - agomelatine, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; stearic acid; colloidal anhydrous silica; sodium starch glycollate type a; maize starch; lactose monohydrate; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; indigo carmine aluminium lake; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; glycerol - treatment in adults of: - of major depression (mdd) including prevention of relapse - generalised anxiety disorder (gad)

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - agomelatine, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; stearic acid; colloidal anhydrous silica; sodium starch glycollate type a; maize starch; lactose monohydrate; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; indigo carmine aluminium lake; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; glycerol - treatment in adults of: - of major depression (mdd) including prevention of relapse - generalised anxiety disorder (gad)

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty 25 mg) - tablet, film coated - excipient ingredients: mannitol; sodium stearylfumarate; silicified microcrystalline cellulose; colloidal anhydrous silica; crospovidone; povidone; magnesium stearate; stearic acid; hypromellose; macrogol 6000; titanium dioxide; purified talc; iron oxide yellow - treatment of major depression in adults including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty 25 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; mannitol; povidone; sodium stearylfumarate; silicified microcrystalline cellulose; magnesium stearate; stearic acid; hypromellose; macrogol 6000; titanium dioxide; purified talc; iron oxide yellow - treatment of major depression in adults including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - agomelatine, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; stearic acid; colloidal anhydrous silica; sodium starch glycollate type a; maize starch; lactose monohydrate; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; indigo carmine aluminium lake; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; glycerol - treatment in adults of: - of major depression (mdd) including prevention of relapse - generalised anxiety disorder (gad)

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty 25 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; mannitol; povidone; silicified microcrystalline cellulose; sodium stearylfumarate; magnesium stearate; stearic acid; hypromellose; macrogol 6000; titanium dioxide; purified talc; iron oxide yellow - treatment of major depression in adults including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - agomelatine, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; stearic acid; colloidal anhydrous silica; sodium starch glycollate type a; maize starch; lactose monohydrate; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; indigo carmine aluminium lake; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; glycerol - treatment in adults of: - of major depression (mdd) including prevention of relapse - generalised anxiety disorder (gad)

Australia - English - Department of Health (Therapeutic Goods Administration)

helix pharmaceuticals pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty 25 mg) - tablet, film coated - excipient ingredients: titanium dioxide; iron oxide yellow; colloidal anhydrous silica; purified talc; povidone; sodium stearylfumarate; stearic acid; silicified microcrystalline cellulose; crospovidone; hypromellose; mannitol; macrogol 6000; magnesium stearate - treatment of major depressive disorder (mdd) in adults including prevention of relapse.